Exhibiting Organizations & Sponsors

		Health Economic Research and Quality of Life Evaluation Services
Helping pharmaceutical, biotechnology and medical device companies quantify and communicate the value of their products in a competitive global marketplace Economic Modeling and Retrospective Analysis Quality of Life / Patient-Reported Outcomes Assessment and Tool Development Strategy Design, Pricing Support and Complementary Services Managed Care Dossier Preparation Manuscript Preparation for Peer-Reviewed Publications and Support for other Professional Communication Activities Patient Registries and Other Prospective Studies For more information, please contact: Chris L. Pashos, Ph.D. Tel: 1 617 520 2935 E-mail: chris_pashos@abtassoc.com

www.academyhealth.org

BIOSTAT

Biostat publishes two exceptional computer programs. These programs, currently used in more than 12,000 institutions including the FDA, CDC, major universities, businesses, and consulting firms, are universally acclaimed for their ease of use, computational accuracy, and sophisticated graphics.

VISIT US AT BOOTH # 8 AND TAKE HOME A FREE TRIAL CD

Power And Precision is a program to find the appropriate sample size for a planned study. Use this program —

• To maximize the likelihood that your study will yield significant and informative results.
• For grant applications. A power analysis section that is presented clearly and with appropriate detail can easily make the difference between a study that is funded and one that is not.
• To teach power analysis as part of a course in research design or statistics.

   www.Power-Analysis.com

Comprehensive Meta Analysis is a program to synthesize data from multiple studies. Use this program —

• To write a systematic review that synthesizes the results of prior studies.
• To present a meta analysis as part of the literature review in the introductory section of a paper or grant application.
• To teach meta analysis as part of a course in research design or statistics.

    www.Meta-Analysis.com  

www.bostonscientific.com

www.CaroResearch.com

www.dymaxium.com

Helping you leave paper behind. In very pretty shapes. Easy-to-use technology supported by people who are just as easy to work with. It’s what we’re all about. Visit us at www.etrials.com for more information.
Electronic Data Capture Electronic Data Reporting Electronic Patient Diaries	Superior technology with a human touch.

Since 1939, F-D-C Reports has published “The Pink Sheet”, the industry standard for regulatory, legislative and business news affecting the pharmaceutical and biotechnology industries. Stay up-to-date on FDA policies, new drug and biological approvals, executive and management moves, financial news and more. In addition to “The Pink Sheet”, F-D-C Reports also publishes Health News Daily, a daily online news service, and “The Gold Sheet”, the “gold” standard for coverage of FDA regulations of drug and biotech manufacturing controls.

Corporate site licenses are also available. This program allows companies to have institutional access to the publication websites by IP Address, E-mail delivery of latest headlines with direct links to full stories on the web and the ability to search 120 days of archives.

F-D-C Reports is now launching FDAAdvisoryCommittee.com Webcasts. You can attend advisory committee meetings without ever leaving your desk. Using the latest in audio/video streaming technology, FDAAdvisoryCommittee.com gives you the whole picture in a specially designed Webcast viewer with links to supporting information, including FDA and sponsor briefing materials.

HEED: the Health Economic Evaluations Database

• the world’s leading International database of economic evaluations in health care
• designed by health economists for researchers in the pharmaceutical industry, academia, health care organizations and consultancies
• comprising 23,500 evaluations in a structured format with a 68 field search capability.
• cover starts 1957 to current date
• covers cost effectiveness analysis and other forms of economic evaluation of medicines, other treatments and medical interventions
• includes studies on cost of illness and cost analysis
• updated monthly
• on CD-ROM and the Internet
  
  Web Site: www.ohe-heed.com
  E-Mail: database@ohe.org

www.ingenix.com

www.innovus.com

Institute of Empirical Health Economics Am Ziegelfeld 28 D-51399 Burscheid, Germany Telephone: +49-(0)2174/7151-0 Telefax: +49-(0)2174/7151-98 E-mail: instfeg@t-online.de Internet: http://www.instfeg.de

The Institute of Empirical Health Economics provides analytical services to health care authorities, to international pharmaceutical companies, to sickness funds and health care insurers and to clinical research programmes.

Our services are:

• Studies and evaluations in hospitals and the GP area
• Decision-tree-analyses and Markov models
• Outcomes research studies
• Consultancy for cost reduction
• SOP's
• Benchmarking
• Moderation and joint meetings with health care providers and payers

Medical Scientists Inc., the visionary leader in predictive modeling software,

combines biological science and advanced technology to provide customers tools and information to reduce costs and improve health outcomes. Our proprietary Medisave™ software offers population-specific decision support technologies and disease-specific models that forecast future medical and non-medical costs. HybridAI™ is a customized rule set utilizing next generation artificial intelligence to identify individuals most likely to incur higher health care costs in the future. Please join us for a detailed demonstration in the exhibit hall or call 617-723-7710 x222.

During ISPOR 7th Annual International Meeting Visit Booth # 5 To learn more about LifeMetrix, Inc. an oncology-focused company that creates best-in-class solutions for disease management and informatics to improve the experience and outcomes of cancer patients

www.MEDTAP.com

MetaWorks® Inc. Harnessing the Power of Data for Healthcare

The Pharmaceutical Industry’s premier source of literature derived evidence-based research studies: • Outcomes Research • Pharmacoeconomic • Pharmacovigilance • Humanistic If you’re considering systematic-review and meta-analysis to harness the vast medical literature, then MetaWorks should be your first stop. Visit us at the ISPOR Exhibition, booth #49, or on the web at www.metaworksinc.com. 10 President’s Landing, Medford, MA 02155

2394 E. Camelback Road Phoenix, AZ 85016

NDCHealth assists its customers in providing quality care at greater efficiency and lower cost by providing end-to-end solutions (point of service systems, intelligent network and information management services) to pharmaceutical manufacturers, pharmacies, hospitals, physicians and payers.

NDCHealth supports over 90% of the nation’s pharmacies, more than 20% of the nation’s hospitals, over 180,000 physicians, over 1,000 payers representing over 4,000 payer plans and more than 75% of all pharmaceutical manufacturers by delivering over 250 products and services.

NDCHealth’s Outcomes Research

The cost of pharmaceutical products in relation to the benefits they provide is an important issue for patients, providers, and third-party payers. Through Outcomes Research, pharmaceutical manufacturers have the means to demonstrate the value of drug interventions. This rapidly growing category of healthcare research assesses the broad impact of your product/intervention from the economic, clinical and humanistic standpoint. Outcomes Research at NDCHealth’s Pharmaceutical Services business unit offers a powerful combination of industry understanding and Outcomes Research expertise to offer comprehensive strategic planning and studies tailored to your requirements. To provide real value for your product/intervention, we integrate all three aspects of Outcomes Research:

• Clinical Outcomes measure medical care associated with a disease or treatment of a disease.
• Humanistic Outcomes assess quality of life, functional status and patient satisfaction.
• Economic Outcomes determine the costs associated with treating a disease.

If you would like more information on NDCHealth's Outcomes Research, please call (800) 778-6711 or visit our web site: www.ndchealth.com.

The Office of Health Policy and Clinical Outcomes
The Office of Health Policy and Clinical Outcomes, one of the few academically based outcomes research centers nationally, has achieved a reputation of quality and excellence. As consultants to academia and industry, we design and conduct outcomes studies (including pharmacoeconomic studies) and performance evaluations. Our accomplishments in the fields of migraine, diabetes, cardiology and senior health care exemplify the depth and breadth of the expertise of the Office staff. The Office furthers our mission of fostering quality and cost-effective healthcare by providing our clients with a wide array of educational programs and services. Supported by the work of our research team, we develop and implement innovative programs for both academia and industry. We serve as a liaison between managed care and the pharmaceutical industry – organizing and moderating proactive and reactive advisory boards, critical to current issues or assumptions. We provide access to decision-makers and thought leaders. We are skilled in assessment, content, and evaluation. We are a facilitator of change – linking our clients’ business needs with initiatives to improve healthcare. For more information on the Office of Health Policy and Clinical Outcomes, please call (215) 955-6969 or visit our website: www.jefferson.edu/ohp.

---

Omnicare Clinical Research is a global Contract Research Organization offering full-service, Phase I-IV, clinical research capabilities across all therapeutic areas. Coupled with our customer-centric focus, we provide clients with exceptional service throughout all phases of drug development. Our global, integrated network of 29 offices with a presence in 27 countries worldwide provides convenient access to expertise and patients around the globe through a single contact point. Contact us at 1-800-290-5766.

www.OmnicareCR.com

---

Data Collection and Reporting for Health Outcomes Studies

OUTCOMES, INC. assists organizations involved in health outcomes studies with on-site and electronic data collection and reporting through its national network of rigorously trained nurse researchers. Our technology solutions include design capabilities for adapting data collection tools to electronic medium, scheduling on-site visits, and on-line transmission for faster and more accurate reporting. Our dedication to quality is demonstrated by our stringent selection criteria for nurse researchers, our annual training and proficiency testing program, and our Inter-Rater Reliability policy for each project (a complete over-read of a statistically valid sample by an experienced RN supervisor to ensure accuracy of data abstractions). Below is a sample of the types of studies in which we participate when accurate and timely data collection and reporting are needed for health outcomes research: Retrospective Health Outcomes Studies Evaluates interventions and other health services for a specific disease process, provider, or demographic subgroup. Comparative Effectiveness Compares outcomes associated with different treatments, diagnostic approaches, or other management strategies (“what works best”). Economic Assessments Compares costs and outcomes for different interventions, or looks at the costs of diseases or treatment without examining outcomes. Patient-Reported Outcomes Studies that report general or disease-specific quality of life, functional status, patient preferences, and/or patient satisfaction. Practice Variations Compares rates of utilization and treatment or service by some categorical group such as region, demographic feature, provider, institution, or time period. Visit our website at www.outcomesinc.com

---

Ovation Research Group has been providing health economics and outcomes research and consulting services to the pharmaceutical industry for over ten years. Ovation combines pioneering experience in health economics with unique insights into achieving cost-effectiveness in various healthcare settings. Our experience in designing and implementing outcomes research includes:

• Product and disease registries
• Prospective naturalistic studies (Phase IIIB/IV)
• Economic analyses
• Patient-reported outcomes/Quality-of-life research
• Decision analysis modeling
• Database analyses
  
  
  Ovation Research Group
  Highland Park, Illinois
  info@ovation.org • www.ovation.org

---

Pharmaceutical and Health Outcomes Sciences
College of Pharmacy




Offering M.S. and Ph.D. programs in Pharmaceutical Sciences with an emphasis on pharmacoeconomics and outcomes research. The Department is comprised of five research-based faculty and an on-going graduate enrollment of approximately eight students. Financial support and tuition reduction is available for qualified students. Strong relationships with the School of Business, School of Public Health, SC Cancer Center, and SC Department of Health and Human Services provide significant research opportunities. The Program has graduated 27 Ph.D. and 11 Masters students who have taken positions of influence in the pharmaceutical industry, academia, consulting firms and professional practice.

For more information about the Program, please contact:

Richard M. Schulz, Ph.D.
Professor and Chair
(803) 777-3891
schulz@cop.sc.edu

---

PharMetrics, Inc. is a leading provider of healthcare market insights based on longitudinal, patient-level information. Through the use of our national patient database and patented technology, PharMetrics supports a range of products targeted at the converging information requirements of healthcare’s major trading partners: pharmaceutical companies, health plans, provider organizations, employers and patients. We provide the depth of real-life information needed to make better business decisions. PharMetrics’ powerful clinical database includes integrated patient-level data comprised of 27 million patients from 42 health plans, including medical services and prescription drug information across the entire continuum of care. Through our nationally projectable database, we track real-life practice-based patient information that enables our pharmaceutical clients to improve their ROI throughout the lifecycle of their drugs. Unlike prescription-only information, PharMetrics data provides the complete picture of a market’s potential through the following applications: Impact prescriber brand choice through the identification and rank ordering of the key drivers of physician prescribing behavior. Identify segments of discrete patient and prescriber groups that drive differences in market share and reveal opportunities to better target the delivery of marketing messages. Identify favorable outcomes in real-life practice that can enhance messaging to physicians, payors and patients. Reveal characteristics of untreated or under-treated patients that can drive overall market growth. Model the historical market uptake of competitor therapies to take advantage of strengths/weaknesses of competitor drug launch experience. Determine the lifetime value of patients and identify the profile of the most desirable patients groups. For additional information, please contact Barbara Levine, VP of Sales, 203.321.2186 or blevine@pharmetrics.com

---

www.pai2.com

---

1175 North Service Road West, Oakville, ON L6M 2W1 CANADA
Tel: 905-465-3090, Fax: 905-465-3091
Montréal 450-663-9748
Email: ideas@pharmideas.com
www.pharmideas.com

Pharmacoeconomics, epidemiology, and outcomes research for

Drug development plans
Product / Market valuation
Clinical trial support
Price justification
Reimbursement / Formulary listing
Marketing / Post-marketing

Canadian expertise and international experience

---

www.polidais.com

---

Premier’s Pharmaceutical Research Services group provides inpatient drug utilization and other aggregate hospital data and research services. We utilize clinical, financial, and demographic inpatient metrics from Premier's Perspective™ Data Warehouse, the nation's largest and most complete repository of clinical and financial resource utilization data. Premier provides more than just data. We provide market researchers and brand managers with the information needed to successfully launch a new product or reposition a medication in a mature market. Before a product is launched, we can help you determine:

Market share Physician specialty targeting Market opportunity Managed care strategy Patient segmentation by diagnosis and procedure Competition   Patient flow

Once a product is on the market, we can analyze:

Drug switching Comparative outcomes Market trends Changes in market share Therapeutic data mart Physician utilization by specialty Cost of care Competitive drug intelligence

---

 

www.rtihs.org

---

Only Solucient provides complete health outcomes research through its unique inpatient and outpatient databases. Solucient’s clinicians, epidemiologists, and statisticians use Solucient’s hospital and retail healthcare databases to conduct health outcomes research that includes: 

• Outcomes measurement studies
• Market forecasting and tracking
• Patient-centered survey data collection and analysis

Solucient’s research results help pharmaceutical manufacturers discover their products’ strengths for the benefit of their managed markets customers.

 Solucient is the leading source of health care business intelligence. Its mission is to provide comprehensive, results-oriented information to drive business growth, manage costs, and deliver quality care. Solucient's expertise and proven solutions enable pharmaceutical companies, providers, payers and employers to achieve results and realize value. By bridging the gap between data and information, knowledge and value, Solucient drives intelligent business decisions. 

For more information, contact: 

Karen O’Neal Solucient LLC (973) 746-4279 koneal@solucient.com www.solucient.com

---

The Analytica Group The Analytica Group is a research consultancy that provides timely delivery of market-driven Health Economics and Outcomes Research. Based in Manhattan, the group is currently conducting research in the United States, Canada, Europe, Latin America, and Asia. The multi-national and multi-disciplinary staff includes physicians, epidemiologists, economists, engineers, pharmaceutical research scientists, and biostatisticians. The Analytica Group is currently engaged with eight of the top ten pharmaceutical companies in the world.

475 Park Avenue South New York, NY 10016 T: 212-686-4100 F: 212-686-8601

---

 

The Center for Pharmacoeconomic Studies at the College of Pharmacy, University of Texas

The Center for Pharmacoeconomic Studies at the College of Pharmacy, University of Texas provides research and educational services to the pharmaceutical industry, pharmacy associations and state and federal agencies. This Center has combined the strengths of clinical practitioners with economic, policy and marketing and social behavioral researchers to conduct studies to measure the economic, humanistic and clinical outcomes related to pharmaceutical products and pharmacy and health care services. The Center has 11 researchers and is recognized as a national leader in outcomes research and educational programming. For further information, call (512) 471-6892 or email: marvshepherd@mail.utexas.edu

---

Peer Review/Rapid Publication The Journal of Applied Research In Clinical and Experimental Therapeutics promotes excellence in the clinical practice of medicine by disseminating fundamental scientific, diagnostic, and treatment knowledge gained from prospective and retrospective research in a timely manner. The Journal fulfills its mission through rapid peer review of each submitted article, and publication of all articles within 90 days of acceptance. The journal will consider submissions from every legitimate specialty, and is especially interested in: -Clinical and preclinical drug trials -Comparative drug studies -Pharmacoeconomic and outcomes research For a Sample Copy of the Journal, please contact us at: 267 566-0270, or visit our website at www.jrnlappliedresearch.com

 

---

Offers unique perspective with strong understanding of health care policy, managed care, physician organizations, clinical development, regulatory environment, and international pharmaceutical marketing. Incorporates state-of-the-art informatics tools and data to provide innovative solutions.
	Development			Pre-Launch		Commercialization
	Objective Determine economic viability Build market need Approach Initial economic story Burden of illness			Objective Facilitate coverage and payment Approach Economic strategic plan Modeling studies Value message testing		Objective Life-cycle management Assess long-term outcomes and cost-effectiveness Approach Claims analysis Economic and financial modeling
Outcomes Research areas include:
		Global economic modeling
		Development, validation, and implementation of QOL and patient satisfaction measures
		Prospective pharmacoeconomic research design and analysis
		Sophisticated retrospective claims analysis
		Product and disease-specific patient registries
	Offices in the United States, Europe, and Asia/Pacific.   The Lewin Group can bring you strategies and services that bridge product development and commercialization, and increase product sales     www.lewin.com

www.lewin.com

---

MEDSTAT Pharmaceutical Research Services… A leader in providing research and normative databases to support drug discovery and post-launch analytics. MEDSTAT can help you: • Assess economic implications of drugs in the marketplace • Determine clinical effectiveness in naturalistic settings • Design economic protocols for clinical trials • Monitor drug/disease market share • Undertake market sizing of potential leads MEDSTAT’s well-published researchers are supported by the MarketScan® Research Databases, the analytical and normative gold standard for the pharmaceutical industry. Please contact us for more information: ISPOR Booth 53 • www.medstat.com tony.likovich@medstat.com • (805) 681-5853

 

---

The 1993 NIH Revitalization Act created a National Information Center on Health Services Research and Health Care Technology (NICHSR) at the National Library of Medicine to improve "..the collection, storage, analysis, retrieval, and dissemination of information on health services research, clinical practice guidelines, and on health care technology, including the assessment of such technology." The overall goals of the NICHSR are: to make the results of health services research, including practice guidelines and technology assessments, readily available to health practitioners, health care administrators, health policy makers, payers, and the information professionals who serve these groups; to improve access to data and information needed by the creators of health services research; and to contribute to the information infrastructure needed to foster patient record systems that can produce useful health services research data as a by-product of providing health care. Please visit us in the exhibit hall Visit our Web Site: www.nlm.nih.gov/nichsr/ Email: nichsr@nlm.nih.gov

 

---

www.treeage.com

---

Weboutcome is a dedicated outcome solutions provider, providing software, systems and services for outcome studies. Formed by physicians to meet the increasing needs of managing outcomes data in the clinical environment, Weboutcome prides itself on meeting and understanding both the clinical and technical issues of rapidly deploying and evolving an outcomes study to fulfil business need. Located in London and operating globally, Weboutcome systems are used by a variety of outcomes stakeholders including pharmaceutical and medical device companies, physician groups, and government agencies. Weboutcome is backed by BUPA, a leading international health and care group with a turnover in excess of $3 billion. We have core competencies in a number of areas including clinical, information technology, data protection, security, project management and pharmaceutical sales and marketing Weboutcome's vision is "to be a trusted partner delivering innovative outcome solutions, partnering with market leaders and employing highly skilled people who maintain client focus". Weboutcome's mission is "to help clients plan, implement and manage successful business outcome solutions". To achieve its vision and mission, Weboutcome focusses on developing a company with people who respect diversity, actively share knowledge, continuously improve and always act with integrity. Please don’t hesitate to contact Deborah Browne or Dr John Wilson at ISPOR. We are located at Booth 29 and look forward to meeting with you. Tel: + 44 20 7953 7423   www.weboutcome.com   email: enquiries@weboutcome.com

7th Annual International Meeting

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2008 International Society for Pharmacoeconomics and Outcomes Research. All rights reserved under International and Pan-American Copyright Conventions. 
Website design by Eagle Systems USA, Inc.